Study title: Abacavir pharmacokinetics during chronic therapy in HIV-1 infected adolescents and young adults
| Type of medicine: Centrally authorised medicines | |||||
| Therapeutic area: Virus Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: abacavir | |||||
| ATC code: J05AF06 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: PACTGP1052 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | Y | |